MDMA-Assisted Psychotherapy for PTSD

The SoundMind Center will be among the first Expanded Access Sites for MDMA-Assisted Psychotherapy

The Multidisciplinary Association for Psychedelic Studies (MAPS) – a nonprofit whose aim is to get MDMA FDA approved by 2021 – will be spearheading phase 3 trials along with others in the coming years. During this next phase of research there will also be the possibility for Expanded Access Clinics – so that patients who aren’t able to enroll in phase 3 research studies will be able to be treated elsewhere at designated clinics around the country. 

The SoundMind Center is excited to be among the first group of of Expanded Access sites to be opening. Check out our website for more information:

You can read more about this breakthrough therapy here.